Next Article in Journal
Intrinsic Properties of Multi-Layer TiO2/V2O5/TiO2 Coatings Prepared via E-Beam Evaporation
Previous Article in Journal
Investigation of the Structure and Corrosion Resistance of Novel High-Entropy Alloys for Potential Biomedical Applications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Application of Raney Al-Ni Alloy for Simple Hydrodehalogenation of Diclofenac and Other Halogenated Biocidal Contaminants in Alkaline Aqueous Solution under Ambient Conditions

1
Chemical Technology Group, Institute of Environmental and Chemical Engineering, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
2
Joint Laboratory of Solid State Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
3
GEOtest, a.s., Šmahova 1244/112, 627 00 Brno, Czech Republic
4
Department of General and Inorganic Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
*
Author to whom correspondence should be addressed.
Materials 2022, 15(11), 3939; https://doi.org/10.3390/ma15113939
Submission received: 17 April 2022 / Revised: 25 May 2022 / Accepted: 30 May 2022 / Published: 31 May 2022

Abstract

:
Raney Al-Ni contains 62% of Ni2Al3 and 38% NiAl3 crystalline phases. Its applicability has been studied within an effective hydrodehalogenation of hardly biodegradable anti-inflammatory drug diclofenac in model aqueous concentrates and, subsequently, even in real hospital wastewater with the aim of transforming them into easily biodegradable products. In model aqueous solution, complete hydrodechlorination of 2 mM aqueous diclofenac solution (0.59 g L−1) yielding the 2-anilinophenylacetate was achieved in less than 50 min at room temperature and ambient pressure using only 9.7 g L−1 of KOH and 1.65 g L−1 of Raney Al-Ni alloy. The dissolving of Al during the hydrodehalogenation process is accompanied by complete consumption of NiAl3 crystalline phase and partial depletion of Ni2Al3. A comparison of the hydrodehalogenation ability of a mixture of diclofenac and other widely used halogenated aromatic or heterocyclic biocides in model aqueous solution using Al-Ni was performed to verify the high hydrodehalogenation activity for each of the used halogenated contaminants. Remarkably, the robustness of Al-Ni-based hydrodehalogenation was demonstrated even for the removal of non-biodegradable diclofenac in real hospital wastewater with high chloride and nitrate content. After removal of the insoluble part of the Al-Ni for subsequent hydrometallurgical recycling, the low quantity of residual Ni was removed together with insoluble Al(OH)3 obtained after neutralization of aqueous filtrate by filtration.

Graphical Abstract

1. Introduction

The presence of biocidal remedies and other fine chemicals in the water sources and the craving for cost-effective techniques applicable for the decomposition of these non-biodegradable pharmaceuticals has become of major interest [1,2]. Concretely, diclofenac (DCF), fluconazole, hydrochlorothiazide, chlorohexidine, ketoconazole, triclosan, atrazine, simazine and a wide range of other halogenated fine chemicals have attracted attention in recent years since they are often being detected in wastewater treatment plants effluents and/or groundwater. These pollutants are only poorly degraded by traditional wastewater treatments due to their biocidal properties caused by halogens bound in their structures [3,4]. The above-mentioned pollutants emerging from the effluents reach the receiving watercourses, and thus they have negative effects on the aquatic fauna and flora.
Chronic toxicity trials performed on the rainbow trout (Oncorhynchus mykiss) revealed cytological changes in the liver, kidneys and gills after 28 days of exposure to just 1 µg L−1 of DCF. For a concentration of 5 µg L−1, renal lesions were evident, as well as drug bioaccumulation in the liver, kidneys, gills and muscles [5,6]. The occurrence of DCF in different aquatic compartments and effluents of wastewater, surface water and groundwater is detected in a wide low-concentration range from 0.8 ng L−1 up to 4.4 mg L−1 [7,8], which highlighted that the mentioned negative effects are of sufficient magnitude to suspect chronic toxicity in aquatic organisms. Based on such facts, the removal of non-biodegradable, biologically active micropollutants from wastewaters is important to minimize their potential negative effect on all living organisms.
By using separation techniques such as electro-reversible adsorption [9], reverse osmosis [10] or nanofiltration [3,11], the concentration of DCF reaches even hundreds of mg L−1 in the aqueous concentrate (or retentate) produced by these separation methods as waste streams [3,9,10,11]. These low volumes of concentrate (retentate), however, should be effectively treated before discharging to the environment. Due to such reasons, various treatment methods enabling the removal of non-biodegradable organic contaminants were proposed earlier for the removal of DCF, including advanced oxidation processes (AOPs) [1,10,12,13,14], electron beam irradiation [15] and/or reduction (hydrodehalogenation (HDH)) processes [4,10].
Generally, the main disadvantage of oxidation processes involves the consumption of high excess oxidants for the formation of biodegradable products. In addition, many of the published papers dealing with the application of AOPs for DCF removal only quantified DCF content in the aqueous solution obtained after tested AOP method treatment [16,17,18,19] (Table 1). Moreover, some papers mentioned the high toxicity of formed primary oxidation or photolysis products [20,21,22].
HDH seems to be, in contrast, a more environmentally friendly process, which allows a significant reduction in the toxicity of the contaminated water and avoids the formation of even more harmful intermediates. The formation of appropriate hydrocarbon from the halogenated contaminant allowed for a dramatic decrease in the ecotoxicity of the aqueous solution obtained after dehalogenation and neutralization to negligible values and enabled their subsequent biodegradation [4,15,23,24].
In most cases, very poison-sensitive platinum-based catalysts are described for the HDH as very expensive species that are, unfortunately, prone to catalyst fouling or poisoning [4,25]. As Nieto-Sandoval et al. observed, even a higher concentration of inorganic chlorides caused the deactivation of used palladium catalysts, which further disadvantages these expensive catalysts for the real applications in wastewater treatment techniques [4].
In addition, noble metals and their soluble compounds proved to be very toxic to aquatic fauna [26,27,28].
The aim of this work was to demonstrate the possibilities of the utilization of the commercial Raney Al-Ni alloy for HDH of the persistent DCF and other halogenated biocides in model and even in real wastewater as the suitable process for the formation of dechlorinated biodegradable products [3,9,10,11]. Commercially available Raney Al-Ni alloy was used because of its observed high HDH activity, which is comparable with platinum- or palladium-based catalysts [4,29,30,31,32]. Furthermore, we proved earlier that the HDH activity of Raney Al-Ni is higher when compared to Al-Cu alloys such as Devarda’s alloy [33]. In an alkaline aqueous solution, Al works as the reductant (i.e., hydrogen generator) and nickel as the HDH catalyst.
After the HDH process, subsequent neutralization of obtained aqueous phase is accompanied by coagulation and flocculation of dissolved Al(III) species, which remove even low concentrations of Ni particles from the resultant reaction mixture (i.e., adsorption of Ni metal particles onto precipitated Al(OH)3). In comparison with platinum-based metals, nickel is described as much less toxic [34,35], and as was described earlier by our group [31], its concentration after the neutralization step, accompanied by removal of precipitated aluminum hydroxide by filtration, is below 10 µg Ni L−1. In the term of this work, a complete operating condition study was carried out, and a kinetic model was accordingly proposed. The recyclability of the used reductant was also evaluated. The versatility of the studied system was demonstrated using a mixture of nine different halogenated biocides dissolved in an aqueous solution and real environmentally relevant aqueous matrices, such as hospital wastewater spiked with DCF.

2. Materials and Methods

2.1. Materials

Diclofenac sodium salt (NaDCF, 98%+), fluconazole (98%+), hydrochlorothiazide (98%+), chlorhexidine (99%+), ketoconazole (98%+), triclosan (Irgasan, 97%+), atrazine (analytical standard), aluminum–nickel alloy (purum, 50% Al basis, 50% Ni basis) and an aqueous solution of NaBH4 (12 wt.% in 14 M NaOH) were delivered by Merck Co. (Prague, Czech Republic). Deuterated chloroform (CDCl3) was purchased from Merck Co. (Prague, Czech Republic). Additional chemicals and solvents in p.a. quality were obtained from a local supplier (Lach-Ner Co., Neratovice, Czech Republic).
A sample of hospital wastewater was stabilized with HNO3 for AOX (adsorbable organically bound halogens) determination [36]. The parameters of hospital wastewater stabilized with HNO3 are: pH = 2.07; [NH4+] = 32.4 mg L−1; [Cl] = 820.7 mg L−1; [Ca+2 + Mg+2] = 4.5 mM; [NO3] = 1213.6 mg L−1; CODCr = 349 mg O2 L−1; AOX = 1.44 mg Cl L−1. The experiments were carried out using deionized water, except where noted otherwise. All operations and manipulations were conducted in the air.

2.2. Experimental Procedure

Laboratory HDH trials were carried out in a magnetically stirred 250 mL round bottom flask at 25 °C. During the reaction, the flask was immersed in a thermostated water bath placed on a magnetic stirrer Heidolph HeiStandart with temperature sensor Pt1000. The 4 mM aqueous NaDCF solution was mixed with an appropriate amount of 0.5 M aq. KOH and filled with water to obtain a 200 mL reaction mixture in which the initial NaDCF concentration was 2 mM (0.59 g L−1), and an appropriate amount of reductant was added (see Table 2 and Figure 1b). The stirring velocity was set to 750 rpm. After the overnight stirring, the residual undissolved part (Ni slurry) was removed from the reaction mixture by simple filtration. The filtrate was subsequently acidified by the addition of 16 wt.% H2SO4 to pH = 2–3 and analyzed by HPLC. The accurate quantity (50 mL) of filtrate of the reaction mixture was extracted by dichloromethane (3 × 20 mL), and the organic phase was evaporated to dryness and dissolved in an appropriate solvent for subsequent NMR analysis (CDCl3).
The comparative experiments and kinetic studies were performed in 250 mL round-bottomed flasks equipped with magnetic stirring on Starfish equipment (Radleys Discovery Technologies, Saffron Walden, UK) installed on a magnetic stirrer Heidolph Heistandard for parallel reactions. The reaction flasks were closed by a tube filled with granulated charcoal.

2.3. Analytical Methods

The content of DCF and its reduction products was determined by HPLC (Agilent 1260 Infinity II, Nucleosil C18 HPLC 5 μm 250 × 3.2 mm Column, DAD detector, Poway, CA, USA). An amount of 5 mL of liquid samples was periodically withdrawn from the reaction vessel, and after acidification, with 1 M HCl to pH = 8–10 (to prevent the precipitation of Al(OH)3), dilution to 25 mL volume with water and subsequent filtration of nickel slurry (0.45 μm membrane filter), the samples were analyzed. The analyses were carried out at 283 nm using 3/7 (v/v) acetonitrile/water as the mobile phase (flow rate 0.9 mL min−1). Moreover, the conversion of DCF to APA was monitored by multinuclear NMR spectroscopy. The NMR spectra were recorded from solutions in CDCl3 and DMSO-d6 on a Bruker AscendTM 500 spectrometer (equipped with Z-gradient 5 mm TBI 500 MHz S1 probe, Karlsruhe, Germany) at frequencies 500.13 MHz for 1H and 125.76 MHz for 13C{1H} at 295 K (see Figures S1–S9 in Supplementary Materials for details).
The content of Al and Ni in the treated water solutions was determined with a GBC Integra XL ICP OES spectrometer iCAP 7400 D (Thermo Scientific, Dreieich, Germany). The BOD5 (biological oxygen demand) and CODCr (chemical oxygen demand) values of the obtained filtrates were determined using Hach–Lange cuvette tests (LCK 555 for BOD5 determination), LCK 514 (for CODCr determination). AOX analyses were performed according to ISO 9562 standard (European ISO 9562, 2004).
The images of samples were obtained using scanning electron microscopes JEOL JSM-5500LV and JEOL JSM7500F (Akishima, Tokyo, Japan).

3. Results and Discussion

3.1. HDH of DCF Using Raney Al-Ni Alloy

In the preliminary set of experiments, optimization of the ratio of the reagents was determined. For the hydrodechlorination (HDC), KOH was used instead of NaOH as the source of biogenic potassium necessary for subsequent bio-treatment of the target HDC product. The results are presented in Table 2. In our work, similarly to Pd0-based HDC [4], (2-(2-chloroanilino)-phenylacetate (Cl-APA) was the sole HDC intermediate formed by substitution of one of the chlorine bound within the DCF structure by hydrogen. In the subsequent HDC step, Cl-APA was further reduced to provide 2-anilinophenylacetate (APA) (Scheme 1).
Differences in HDC efficiency of DCF using various reaction conditions were determined (Table 2). Furthermore, the comparison of DCF reductive removal is depicted in Figure 1a–d (and in the Supplementary Materials in Figures S13–S18). Based on results obtained within run 14 in Table 2, the application of powdered aluminum without Ni is not effective for HDC of DCF. This observation supports that nickel poses a key role in this described HDC process.
The minimal excess of reactants for complete HDC of DCF after 16 h of vigorous stirring at room temperature is at least 10 mol of Al used in the form of Al-Ni alloy and 25 mol of KOH per 1 mol of DCF dissolved in water (in 2 mM aq. DCF) (see Table 2, run 10). By using tap water, 1 mol of DCF was completely reduced to APA using 15 mol of Al (used as Al-Ni alloy) together with 75 mol of KOH (see run No. 3 in Table 2). As can be seen in Figure 1, by using 15 mol of Al in Al-Ni alloy and 75 mol of KOH per 1 mol of DCF, the full HDC was completed after 40 min of producing APA as the final organic sole product (Table 2, run No. 1 and Figure 1). At lower quantities of Al-Ni and KOH, the reaction rate is much slower.
The conversion of HDC reaction (removal of AOX) is strongly dependent on the quantity of produced soluble KAl(OH)4 analyzed by ICP-OES as dissolved Al (see Figure S10 in the Supplementary Materials). Practically, at least 2.6 mmol of Al (68 mg, 340 mg L−1) should be dissolved by a reaction of Al-Ni with KOH and DCF to accomplish a complete HDC of 0.4 mmol of DCF under efficient stirring. It means that complete HDC of 1 mol DCF is accompanied by dissolution of 6.5 mol Al from a total of 10 mol Al added in the form of Al-Ni alloy (Table 2, run No. 10).
Possible mechanisms of the described HDH comprise either (a) in situ generations of hydrogen by the dissolution of Al from Ni2Al3 or 38% NiAl3 crystalline phases occurring in Al-Ni alloy and formation of the catalytically active Raney nickel saturated with produced H2 as the active HDH agent or (b) direct HDH of DCF adsorbed on Al-Ni alloy acting as a galvanic couple, which hydrodehalogenates DCF during oxidation and dissolution of Al. The dissolution of Al enables denudation of the active Al-Ni surface for further HDH process [30].
We observed earlier [27] that the HDC mechanism (HDC based on in situ produced Raney Ni) works in the case of HDC of several chlorinated anilines. In this case, the positive role of glucose as an additive was documented, which influences the formation of Raney Ni nanoparticles from used Al-Ni and enables effective HDH. For verification of this reaction pathway, glucose was added in different quantities to the mixture of DCF dissolved in diluted KOH solution before the addition of Raney Al-Ni. Unfortunately, however, for DCF, we observed that the addition of glucose to the reaction mixture only causes a decrease in the HDC rate (see Figure 1c). The attempts to decrease the required quantity of Al-Ni by the addition of glucose acting as a promoter of highly reactive Ni0 nanoparticles formation (as we published earlier [37] were not successful. This fact could indicate the possible HDC mechanism of DCF, which is based not on a reaction with the activated hydrogen adsorbed on (nano)nickel surface, as was assumed for HDC of 3-chloroaniline [32], but was in all probability caused by the nickel catalyzed reductive action of aluminum in alkali after adsorption of DCF on the surface of the Al-Ni alloy composing local galvanic couples between active Al anode and Ni cathode (Ni catalyzed dissolving-metal reduction) [30].
To corroborate the hypothesis of the mechanism described, vide supra, the efficiency of adsorption of DCF on the Al-Ni surface was proved using a neutral 2 mM aqueous solution of NaDCF (0.635 g L−1) and 1.65 g L−1 of Al-Ni alloy in the absence of KOH (see Figure S11 in the Supplementary Materials for the experimental data). It was found that the concentration of DCF along the adsorption experiment had decreased by ca. 25% after 30 min. These results thus corroborated the contribution of DCF adsorption on the Al-Ni surface to cause a subsequent HDC reaction on the Al-Ni surface according to the proposed mechanism.
This phenomenon could be explained by the different course of corrosion of the Al-Ni alloy with alkali metal hydroxides after the addition of glucose to the alkaline aqueous reaction mixture. The action of 1 wt.% aqueous KOH solution causes deep (pitting) corrosion of Al-Ni, while the addition of glucose to these mentioned alkali metal hydroxide solutions only induces superficial corrosion of Al-Ni, which is accompanied by the slowdown of the dissolution of Al from the Al-Ni alloy and the subsequent decrease in the HDC reaction rate (see Figure 2a–c and Figure S12a–c in the Supplementary Materials for the experimental data).

3.2. Kinetic Modelling

For a comparison of reaction rates, a simple kinetic model based on the reaction pathway shown in Scheme 1, considering the pseudo-first-order, was employed.
The following kinetics equations were proposed
r D C F = d c D C F d t = k 1 c D C F
r C l - A P A = d c C l - A P A d t = k 1 c D C F k 2 c C l - A P A
r A P A = d c A P A d t = k 2 c C l - A P A
where CDCF, CCl-APA and CAPA are concentrations of DCF, Cl-APA and APA in the solution and k1 and k2 are the apparent first-order rate constants (see Scheme 1 in the main document). The integration of the Equations (1)–(3) was performed with the following initial values t = 0: CDCF = CDCF,0; CCl-APA = CAPA = 0 and Equations (4)–(6) were obtained
c D C F = c D C F , 0 e k 1 t
c C l - A P A = c D C F , 0 k 1 k 2 k 1 ( e k 1 t e k 2 t )
c A P A = c D C F , 0 k 2 k 1 [ k 2 ( 1 e k 1 t ) k 1 ( 1 e k 2 t ) ]
The experimental data were simultaneously fitted to Equations (4)–(6).
The following figures (Figure 1a–d and Figures S13–S18 in Supplementary Materials) depict the kinetic studies of selected experiments. One chromatogram from HPLC showing unambiguous separation of DCF, Cl-APA and APA is also included.
The values of kinetic constants k1 and k2 were obtained by minimizing the standard deviation of experimental and calculated values of concentrations of all components of the mixture (DCF, Cl-APA and APA). The standard deviation was within limits from 6% to 20%.
The values of the resulting kinetic parameters are summarized in Table 3. By taking into account the data, one can calculate that for a complete HDC of 1 mol of DCF, it is necessary to use 20 mol of Al and 9.34 mol of Ni in Al-Ni alloy and 25 mol of KOH (see results in Table 3). The proposed pseudo-first-order kinetic model is in good agreement with the experimental results, as can be seen from the example depicted in Figure 1a–d for run No. 1 (and in Figures S13–S18 in the Supplementary Materials).

3.3. Applicability of Used Al-Ni Alloy for HDC

An important shortcoming of HDC is related to the deactivation of the reducing agent Al-Ni (compare runs No. 2 and 15 in Table 2), which is caused by the significant loss of Al during the first reduction step. Thus, the activity of the spent Al-Ni alloy was assessed upon sequential re-use after simple separation of the used Al-Ni slurry from the aqueous phase by sedimentation.
In the subsequent reaction of 2 mM aq. DCF in 150 mM KOH with re-used Al-Ni, only incomplete conversion was achieved after 18 h of stirring at 25 °C (the reaction mixture contains 39% DCF, 8% Cl-APA and 53% APA, AOX = 55 mg Cl L−1), which corresponds well with the dissolution of 183 mg Al L−1 (only 1.35 mmol remaining Al was dissolved in the reaction mixture after 18 h in the second run; see Table 2, run 2).
Due to the low content of the remaining active Al in the once used Al-Ni alloy, the HDC using an excess of external reductant NaBH4 (31 mmol) in 0.96 M NaOH was performed (see runs No. 3 and 15 in Table 2). After 18 h of vigorous stirring, 89% APA, 3% Cl-APA and 8% of DCF content were determined by HPLC in the resulting reaction mixture, and the content of AOX value decreased from 123.5 12.5 mg Cl L−1 to AOX = 12.5 mg Cl L−1. Under the severe conditions used in run No. 15, only microcrystals of cubic Ni (no residual Al) were determined by the X-ray powder diffraction in separated and dewatered Ni slurry Figure 2a–c show the morphology of the fresh and used Al-Ni alloy particles applied in this study without and with the addition of glucose, Figure 2d action of NaBH4 in NaOH (used in excess) on used Al-Ni alloy (Run No. 15 in Table 2). (In the Supplementary Materials, the corresponding XRD analyses and Al content of fresh Al-Ni alloy and used Al-Ni are given in Figure S12a–d.)
These results are not sufficient for exhaustive HDC using recycled Al-Ni alloy, but its use hopefully enables potential pretreatment (partial HDC) before the final complete HDC induced by the subsequent addition of a low quantity of the fresh Al-Ni. In order to recycle deactivated Ni0, the hydrometallurgical treatment of spent Ni slurry after the HDC by K2S2O8/H2SO4 was studied, producing NiSO4 [38].
NiSO4, obtained from the spent Al-Ni alloy, was successfully tested as a source of active Ni0 catalyst produced in situ by Al0/KBH4 reduction used in excess of subsequent HDC of DCF, but even in this case, the incomplete HDC of DCF was observed [38]. Using a combination of lower quantities of NiSO4/NaBH4 without the addition of Al only causes, in contrast, low conversion of DCF to APA with high content of Cl-APA (see Table 2, run No. 16).

3.4. Applicability of Ni-Based HDC for Treatment of Water Contaminated with Broad Spectrum of Halogenated Biocides

In order to demonstrate the concept of applicability of Al-Ni within the reductive treatment of wastewater contaminated with a broad spectrum of halogenated biocides, HDC of nine different halogenated aromatic and heterocyclic biocides was investigated (Table 4).
Because atrazine and simazine are the common aqueous contaminants, their broad application as cost-effective and highly efficient herbicides are due to their high mobility and persistence in the environment [39]. Gawel et al. published that nanoparticles of iron are not effective for hydrodehalogenation of atrazine, and Fenton oxidation must be used for its removal [39]. Leonard et al. described nickel catalyst effective for HDC of atrazine caused by pressurized gaseous hydrogen at 5 MPa and 140 °C [40]. Both atrazine and simazine are detoxified by nucleophilic substitution of bound chlorine by the action of alkaline hydrogen peroxide solution [41].
Cetirizine is the broadly used antihistamine applied to treat allergic diseases. It has often been detected as an aqueous pollutant, indicating high stability in the environment [42]. Chemical oxidation methods were tested for cetirizine removal using sodium hypochlorite with a low degradation effect and UV-catalyzed oxidation resulting in high degradation efficiency [43,44].
Chlorhexidine and triclosan are broadly used disinfectants. They are detectable in high concentrations in hospital and domestic wastewaters [45]. Photocatalytic methods were tested for detoxification of chlorhexidine and triclosan [46,47,48]. In the case of triclosan, extremely toxic polychlorinated dibenzo-p-dioxines (PCDDs) were identified as oxidative by-products [48].
Fluconazole and ketoconazole are commonly used antifungal agents [49]. Photocatalytic processes were described as effective for the treatment of these antifungal drugs [50].
Hydrochlorothiazide is widely used diuretic [51]. The ecotoxicity of this drug and even of its oxidation products is mentioned in the literature [52]. The composition of starting aqueous solution contaminated with the above-mentioned nine halogenated biocides (WW) and the effect of tested reductants is depicted in Table 4. It is evident that the application of sole NaBH4 has a negligible effect on pollutants removal (Table 4, Run 1). This observation is in good agreement with the known fact that NaBH4 is not an effective HDH agent without the co-action of metal catalysts. By using the Raney Al-Ni/NaOH procedure, the concentrations of pollutants decrease significantly; however, the concentration of some of them (Triclosan, DCF, Fluconazole and Simazine) remains over 1 μg L−1 (Table 4, Run 2). Similarly, by applying the NaBH4/NiSO4 procedure (from NiSO4 obtained during recycling of spent Al-Ni alloy [38]), some of the pollutants are removed effectively; however, concentrations of triclosan, DCF, Atrazine and Simazine still remain over 1 μg L−1 (Table 4, Run 3).
By applying such an approach followed by the pretreatment by NiSO4/NaBH4 and subsequent Al-Ni/NaOH reduction, it is thus clearly possible to completely remove the majority of halogenated species from the model wastewater sample (i.e., the concentration of the respective halogenated pollutants decreases from ca 10–16 μg L−1 to max. 0.3 μg L−1; see Run 4 in Table 4).

3.5. Applicability of Ni-Based HDC for Treatment of the Real Water Matrix

For another demonstration of the robustness of the presented Al-Ni-based HDC concept, the efficiency of the Al-Ni alloy was evaluated using hospital wastewater spiked with DCF (1 mM DCF). Due to the stabilization of this hospital wastewater with added HNO3, the number of reducible compounds in the spiked hospital wastewater was high ([NO3] = 1213.6 mg L−1; AOX = 73.5 mg Cl L−1; BOD5 = 219 mg O2 L−1; CODCr = 1374 mg O2 L−1, another characteristics are mentioned Section 2.1).
Based on these circumstances, the preliminary reduction in easily reducible compounds was performed by the addition of 1 M aqueous NiSO4 and followed by a dropwise addition of 12 wt.% NaBH4 in 14 M aqueous NaOH for alkalization of the treated water solution. In the subsequent step, Al-Ni alloy was added, and the resulting suspension was stirred for 240 min. Afterward, the obtained filtrate contained only APA according to the HPLC while AOX = 0.17 mg Cl L−1. After neutralization and separation of Al(OH)3, the biodegradability was determined by measurement of ratio BOD/COD = 0.485, which indicates easy biodegradability of organic compounds in the resulting treated wastewater. No significant inhibition effect on HDC, caused by high inorganic chloride content in this hospital wastewater, was observed in this case (see Table 5).

4. Conclusions

This study investigated the potential use of cheap and commercially available Al-Ni alloy within catalytic HDC of DCF in an alkaline aqueous solution. It was determined that commercial Raney Al-Ni alloy exhibited the highest HDC reactivity of DCF in the diluted aqueous KOH or NaOH solution. DCF, even in a concentration of 2 mM (0.59 g L−1 DCF), was completely dechlorinated into APA within 50 min by 1.1 g L−1 Al-Ni loading using 5.6 g L−1 KOH at room temperature. After the HDC process, the aqueous phase was neutralized and separated from the precipitated Al(OH)3. In the obtained filtrate, the remaining organic compounds are easily biodegradable. The recyclability of the used Al-Ni with or without the co-action of the aqueous solution of NaBH4 in NaOH was tested. Even under these conditions, HDC efficiency above 50% was achieved. In general, we demonstrated that a decrease in Al content in Al-Ni alloy is accompanied by a decrease in HDC activity of Al-Ni even when an additional reductant was added. When using NiSO4 with an excess of NaBH4 as the source of in situ generated HDC (i.e., Ni0) agent, only incomplete HDC efficiency of DCF was observed. On the other hand, we demonstrated that NaBH4/NiSO4 reagent is applicable for the pretreatment of a mixture of halogenated biocides in an aqueous solution or for the pretreatment of real hospital wastewater containing high concentrations of chlorides, reducible nitrates and DCF. Subsequent application of Al-Ni alloy to the obtained alkaline pretreated wastewater enables the completion of HDC of chlorinated aromatic or heterocyclic contaminants.
We proved that the concentration of nickel in treated aqueous solution after neutralization and separation of insoluble part is below 10 μg Ni/L due to the treatment caused by coagulation and flocculation of dissolved Al(III) species (precipitation of Al(OH)3), which acts as a sorbent of the Ni metal particles. Used Ni is completely recyclable (similarly to catalysts based on noble metals), as we documented in our previous works [33].
The described method was tested for real wastewater treatment with a content of chlorinated benzenes [53].

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ma15113939/s1, Figure S1: General NMR numbering of DCF (X = Cl) and APA (X = H). Figure S2: 1H NMR spectrum of DCF in DMSO-d6. δ (ppm): 10.32 (s, 1H), 7.44 (d, 2H), 7.06 (m, 2H), 6.91 (t, 1H), 6.73 (t, 1H), 6.24 (d, 1H), 3.39 (s, 2H). Resonances at 3.38 and 2.50 ppm correspond to water and residual DMSO, respectively. Figure S3: 13C{1H} NMR spectrum of DCF in DMSO-d6. δ (ppm): 175.2, 143.4, 138.2, 129.9, 129.0, 128.9, 128.5, 125.6, 123.7, 119.7, 115.4, 44.7. Resonance at 39.5 ppm corresponds to DMSO. Figure S4: 1H NMR spectrum of APA in DMSO-d6. δ (ppm): 7.58 (m, 2H), 7.45 (t, 1H), 7.42 (d, 2H), 7.35 (d, 1H), 7.21 (t, 1H), 7.06 (t, 1H), 6.70 (d, 1H), 3.75 (s, 2H). Signal of the NH fragment was not observed. Resonances at 3.37 and 2.50 ppm correspond to water and residual DMSO, respectively. Figure S5: 13C{1H} NMR spectrum of APA in DMSO-d6. δ (ppm): 173.9, 144.8, 134.6, 129.6, 127.9, 127.6, 126.8, 124.8, 124.7, 122.4, 108.7, 35.4. Resonance at 39.5 ppm corresponds to DMSO. Figure S6: 1H NMR spectrum of APA in CDCl3. δ (ppm): 7.55 (m, 2H), 7.44 (m, 3H), 7.33 (d, 1H), 7.23 (t, 1H), 7.09 (t, 1H), 6.80 (d, 1H), 5.65 (broad, 1H), 3.74 (s, 2H). Resonances at 7.27 and 1.63 ppm correspond to residual CHCl3 and water, respectively. Figure S7: 13C{1H} NMR spectrum of APA in CDCl3. δ (ppm): 174.7, 145.5, 134.7, 129.9, 128.3, 128.0, 126.8, 124.8, 124.5, 123.0, 109.6, 36.3. Resonance at 77.2 ppm corresponds to CDCl3. Figure S8: Comparison of aromatic regions of 1H NMR spectra of starting DCF (red) and product of its hydrodechlorination, APA (blue). Figure S9: Comparison of aromatic regions of 13C{1H} NMR spectra of starting DCF (red) and product of its hydrodechlorination, APA (blue). Figure S10: Dependence of decrease in AOX on quantity of dissolved Al; 6 mmol Al (in Al-Ni) + 30 mmol KOH per 0.4 mmol of DCF dissolved in 200 mL of water (see Table 1, run No.1). Figure S11: Adsorption of DCF onto the Al-Ni alloy in absence of KOH ([NaDCF] = 635 mg L−1 and [Al-Ni] = 1.65 g L−1; 25 °C). Figure S12: Comparison of the HDC rates of DCF using different amounts of KOH (0.4 mmol DCF + 4 mmol Al (in Al-Ni)). Figure 12a: XRD spectrum of starting commercial Raney Al-Ni alloy with composition ca. 62% Ni2Al3 + 38% NiAl3. Figure S12b: XRD of eroded Al-Ni alloy after hydrodechlorination process (run No. 7 in Table 1) still contains some Al: 8% Ni2Al3 + 92% Ni0.879 Al0.121. Figure S12c: XRD of used Al-Ni alloy in co-action of glucose, run No. 8 in Table 1: 72% Ni0.879Al0.121 + 28% Ni2Al3 (less Al is dissolved compared with run 7 in Table 1). Figure S12d: XRD of Ni slurry (cubic Ni0) obtained by action of NaOH/NaBH4 (run No.15 in Table 1). Figure S13: Results of experiment No. 7, mentioned in Table 1 (0.4 mmol DCF + 4 mmol Al (in Al-Ni) + 20 mmol KOH). Experimental (symbols) and model fit (solid lines). Figure S14: Results of experiment No. 10 in Table 1 (0.4 mmol DCF + 4 mmol Al (in Al-Ni) + 10 mmol KOH). Experimental (symbols) and model fit (solid lines). Figure S15: Results of experiment No. 5 in Table 1 (0.4 mmol DCF + 4 mmol Al (in Al-Ni) + 40 mmol KOH). Experimental (symbols) and model fit (solid lines). Figure S16: Results of experiment No. 6 in Table 1 (0.4 mmol DCF + 4 mmol Al (in Al-Ni) + 30 mmol KOH). Experimental (symbols) and model fit (solid lines). Figure S17: Results of experiment No. 4 in Table 1 (0.4 mmol DCF + 5 mmol Al (in Al-Ni) + 25 mmol KOH). Experimental (symbols) and model fit (solid lines). Figure S18: Results of experiment No. 8 in Table 1 (0.4 mmol DCF + 4 mmol Al (in Al-Ni) + 5 mmol glucose + 20 mmol KOH). Experimental (symbols) and model fit (solid lines). Figure S19: Example of chromatogram from HPLC, experiment No. 3 from Table 1, reaction time 20 min. First signal corresponds to APA (retention time 3.2 min.), second to Cl-APA (retention time 4.5 min.) and third to DCF (retention time 5.9 min.). Table S1: Characteristic MRM transitions of targeted analytes. Table S2: Structures and formulas of biocides mentioned in Table S1. References [54,55,56,57,58,59,60,61] are cited in the Supplementary Materials.

Author Contributions

Conceptualization, T.W. and P.Š.; methodology, H.B.; software, L.B., P.Š. and M.V.; validation, H.B., B.K. and P.L.; formal analysis, H.B.; investigation, H.B., B.K., T.W. and P.L.; resources, T.W.; data curation, H.B., M.V. and L.B.; writing—original draft preparation, T.W. and P.Š.; writing—review and editing, T.W. and P.Š.; visualization, H.B.; supervision, T.W.; project administration, T.W.; funding acquisition, T.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the financial support for excellent technological teams from the Faculty of Chemical Technology, University of Pardubice.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jin, X.; Peldszus, S.; Huck, P.M. Reaction kinetics of selected micropollutants in ozonation and advanced oxidation processes. Water Res. 2012, 46, 6519–6530. [Google Scholar] [CrossRef] [PubMed]
  2. Larsson, D.G.J.; Pedro, C.; Paxeus, N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 2007, 148, 751–755. [Google Scholar] [CrossRef] [PubMed]
  3. Barbosa, M.O.; Moreira, N.F.F.; Ribeiro, A.R.; Pereira, M.F.R.; Silva, A.M.T. Occurrence and removal of organic micropollutants: An overview of the watch list of EU Decision 2015/495. Water Res. 2016, 94, 257–279. [Google Scholar] [CrossRef]
  4. Nieto-Sandoval, J.; Munoz, M.; de Pedro, Z.M.; Casas, J.A. Fast degradation of diclofenac by catalytic hydrodechlorination. Chemosphere 2018, 213, 141–148. [Google Scholar] [CrossRef]
  5. Schwaiger, J.; Ferling, H.; Mallow, U.; Wintermayer, H.; Negele, R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac Part 1: Histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68, 141–150. [Google Scholar] [CrossRef] [PubMed]
  6. Triebskorn, R.; Casper, H.; Heyd, A.; Eikemper, R.; Kohler, H.R.; Schwaiger, J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68, 151–166. [Google Scholar] [CrossRef] [PubMed]
  7. Schröder, P.; Helmreich, B.; Škrbić, B.; Carballa, M.; Papa, M.; Pastore, C.; Emre, Z.; Oehmen, A.; Langenhoff, A.; Molinos, M.; et al. Status of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenac. Environ. Sci. Pollut. Res. 2016, 23, 12835–12866. [Google Scholar] [CrossRef]
  8. Manasfi, R.; Brienza, M.; Ait-Mouheb, N.; Montemurro, N.; Perez, S.; Chiron, S. Impact of long-term irrigation with municipal reclaimed wastewater on the uptake and degradation of organic contaminants in lettuce and leek. Sci. Total Environ. 2021, 765, 142742. [Google Scholar] [CrossRef]
  9. Puga, A.; Pazos, M.; Rosales, E.; Angeles Sanroman, M. Electro-reversible adsorption as a versatile tool for the removal of diclofenac from wastewater. Chemosphere 2021, 280, 130778. [Google Scholar] [CrossRef]
  10. Joo, S.H.; Tansel, B. Novel technologies for reverse osmosis concentrate treatment: A review. J. Environ. Manag. 2015, 150, 322–335. [Google Scholar] [CrossRef]
  11. Beier, S.; Köster, S.; Veltmann, K.; Schröder, H.; Pinnekamp, J. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis. Water Sci. Technol. 2010, 61, 1691–1698. [Google Scholar] [CrossRef] [PubMed]
  12. Sgroi, M.; Snyder, S.A.; Roccaro, P. Comparison of AOPs at pilot scale: Energy costs for micro-pollutants oxidation, disinfection by-products formation and pathogens inactivation. Chemosphere 2021, 273, 128527. [Google Scholar] [CrossRef] [PubMed]
  13. Rosales, E.; Diaz, S.; Pazos, M.; Angeles Sanroman, M. Comprehensive strategy for the degradation of anti-inflammatory drug diclofenac by different advanced oxidation processes. Sep. Pur. Technol. 2019, 208, 130–141. [Google Scholar] [CrossRef]
  14. Wang, S.; Zhang, W.; Jia, F.; Fu, H.; Liu, T.; Zhang, X.; Liu, B.; Nunez-Delgado, A.; Han, N. Novel Ag3PO4/boron-carbon-nitrogen photocatalyst for highly efficient degradation of organic pollutants under visible-light irradiation. J. Environ. Manag. 2021, 292, 112763. [Google Scholar] [CrossRef]
  15. Tominaga, F.K.; dos Santos Batista, A.P.; Costa Teixeira, A.C.S.; Borrely, S.I. Degradation of diclofenac by electron beam irradiaton: Toxicity removal, by-products identification and effect of another pharmaceutical compound. J. Environ. Chem. Eng. 2018, 6, 4605–4611. [Google Scholar] [CrossRef]
  16. Kowalska, K.; Roccamante, M.; Cabrera Reina, A.; Plaza-Bolanos, P.; Oller, I.; Malato, S. Pilot-scale removal of microcontaminants by solar-driven photo-Fenton in treated municipal effluents: Selection of operating variables based on lab-scale experiments. J. Environ. Chem. Eng. 2021, 9, 104788. [Google Scholar] [CrossRef]
  17. Oliveros, A.N.; Pimentel, J.A.I.; de Luna, M.D.G.; Garcia-Segura, S.; Abarca, R.R.M.; Doong, R.-A. Visible-light photocatalytic diclofenac removal by tunable vanadium pentoxide/boron-doped graphitic carbon nitride composite. Chem. Eng. J. 2021, 403, 126213. [Google Scholar] [CrossRef]
  18. Gerbaldo, M.V.; Marchetti, S.G.; Elías, V.R.; Mendieta, S.N.; Crivello, M.E. Degradation of anti-inflammatory drug diclofenacusing cobalt ferrite as photocatalyst. Chem. Eng. Res. Design 2021, 166, 237–247. [Google Scholar] [CrossRef]
  19. Costa, E.P.; Roccamante, M.; Plaza-Bolaños, P.; Oller, I.; Agüera, A.; Amorim, C.C.; Malato, S. Aluminized surface to improve solar light absorption in open reactors: Application for micropollutants removal in effluents from municipal wastewater treatment plants. Sci. Total Environ. 2021, 755, 142624. [Google Scholar] [CrossRef]
  20. Ofrydopoulou, A.; Evgenidou, E.; Nannou, C.; Vasquez, M.I.; Lambropoulou, D. Exploring the phototransformation and assessing the in vitro and in silico toxicity of a mixture of pharmaceuticals susceptible to photolysis. Sci. Total Environ. 2021, 756, 144079. [Google Scholar] [CrossRef]
  21. Calza, P.; Sakkas, V.A.; Medana, C.; Baiocchi, C.; Dimou, A.; Pelizzetti, E.; Albanis, T. Photocatalytic degradation study of diclofenac over aqueous TiO2 suspensions. Appl. Catal. B Environ. 2006, 67, 197–205. [Google Scholar] [CrossRef]
  22. Perisic, D.J.; Kovacic, M.; Kusic, H.; Stangar, U.L.; Marin, V.; Bozic, A.L. Comparative analysis of UV-C/H2O2 and UV-A/TiO2 processes for the degradation of diclofenac in water. React. Kinet. Mech. Catal. 2016, 118, 451–462. [Google Scholar] [CrossRef]
  23. Heck, K.N.; Garcia-Segura, S.; Westerhoff, P.; Wong, M.S. Catalytic Converters for Water Treatment. Acc. Chem. Res. 2019, 52, 906–915. [Google Scholar] [CrossRef] [PubMed]
  24. Weidlich, T.; Prokes, L.; Pospisilova, D. Debromination of 2,4,6-tribromophenol coupled with biodegradation. Cent. Eur. J. Chem. 2013, 11, 979–987. [Google Scholar] [CrossRef]
  25. Nieto-Sandoval, J.; Ortiz, D.; Munoz, M.; de Pedro, Z.M.; Casas, J.A. On the deactivation and regeneration of Pd/Al2O3 catalyst for aqueousphase hydrodechlorination of diluted chlorpromazine solution. Catal. Today 2020, 356, 255–259. [Google Scholar] [CrossRef]
  26. Florea, A.M.; Büsselberg, D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 2006, 19, 419–427. [Google Scholar] [CrossRef]
  27. Zimmermann, S.; Wolff, C.; Sures, B. Toxicity of platinum, palladium and rhodium to Daphnia magna in single and binary metal exposure experiments. Environ. Pollut. 2017, 224, 368–376. [Google Scholar] [CrossRef]
  28. Pawlak, J.; Łodyga-Chruścińska, E.; Chrustowicz, J. Fate of platinum metals in the environment. J. Trace Elem. Med. Biol. 2014, 28, 247–254. [Google Scholar] [CrossRef]
  29. Wu, K.; Qian, X.; Chen, L.; Xu, Z.; Zheng, S.; Zhu, D. Effective liquid phase hydrodechlorination of diclofenac catalysed by Pd/CeO2. RSC Adv. 2015, 5, 18702–18709. [Google Scholar] [CrossRef]
  30. Yang, B.; Zhang, F.; Deng, S.; Yu, G.; Zhang, H.; Xiao, J.; Shi, L.; Shen, J. A facile method for the highly efficient hydrodechlorination of 2-chlorophenol using Al-Ni alloy in the presence of fluorine ion. Chem. Eng. J. 2012, 209, 79–85. [Google Scholar] [CrossRef]
  31. Weidlich, T.; Kamenicka, B.; Melanova, K.; Cicmancova, V.; Komersova, A.; Cermak, J. Hydrodechlorination of Different Chloroaromatic Compounds at Room Temperature and Ambient Pressure-Differences in Reactivity of Cu- and Ni-Based Al Alloys in an Alkaline Aqueous Solution. Catalysts 2020, 10, 994. [Google Scholar] [CrossRef]
  32. Perko, J.; Kamenicka, B.; Weidlich, T. Degradation of the antibacterial agents triclosan and chlorophene using hydrodechlorination by Al-based alloys. Monatsh. Chem. 2018, 149, 1777–1786. [Google Scholar] [CrossRef]
  33. Weidlich, T.; Krejcova, A.; Prokes, L. Hydrodebromination of 2,4,6-tribromophenol in aqueous solution using Devarda’s alloy. Monatsh. Chem. 2013, 144, 155–162. [Google Scholar] [CrossRef]
  34. Pennazio, S. Metals Essentials for Plants: The Nickel Case. Theor. Biol. Forum 2012, 105, 83–98. [Google Scholar]
  35. Brown, P.H.; Welch, R.M.; Cary, E.E. Nickel: A micronutrient essential for higher plants. Plant Physiol. 1987, 85, 801–803. [Google Scholar] [CrossRef] [PubMed]
  36. European ISO 9562; Water Quality—Determination of Adsorbable Organically Bound Halogens (AOX). European Committee for Standardization: Brussels, Belgium, 2004; ISO Org. Data, 2004. Available online: https://www.iso.org/standard/36918.html (accessed on 28 December 2021).
  37. Weidlich, T.; Oprsal, J.; Krejcova, A.; Jasurek, B. Effect of glucose on lowering Al-Ni alloy consumption in dehalogenation of halogenoanilines. Monatsh. Chem. 2015, 146, 613–620. [Google Scholar] [CrossRef]
  38. Bendova, H.; Weidlich, T. Application of diffusion dialysis in hydrometallurgical separation of nickel from spent Raney Ni catalyst. Sep. Sci. Technol. 2018, 53, 1218–1222. [Google Scholar] [CrossRef]
  39. Gawel, A.; Seiwert, B.; Suhnholz, S.; Schmitt-Jansen, M.; Mackenzie, K. In-situ treatment of herbicide-contaminated groundwater–Feasibility study for the cases atrazine and bromacil using two novel nanoremediation-type materials. J. Hazard. Mater. 2020, 393, 122470. [Google Scholar] [CrossRef]
  40. Leonard, D.K.; Ryabchuk, P.; Anwar, M.; Dastgir, S.; Junge, K.; Matthias, B. A Convenient and Stable Heterogeneous Nickel Catalyst for Hydrodehalogenation of Aryl Halides Using Molecular Hydrogen. ChemSusChem 2022, 15, 202102315. [Google Scholar] [CrossRef]
  41. Mu, Y.; Chen, Y.; Fu, Q.; He, P.-Y.; Sun, Q.; Zou, J.-P.; Zhang, L.; Wang, D.; Luo, S. Transformation of Atrazine to Hydroxyatrazine with Alkali-H2O2 Treatment: An Efficient Dechlorination Strategy under Alkaline Conditions. ACS EST Water 2021, 1, 1868–1877. [Google Scholar] [CrossRef]
  42. Golovko, O.; Kumar, V.; Fedorova, G.; Randak, T.; Grabic, R. Seasonal changes in antibiotics, antidepressants/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant. Chemosphere 2014, 111, 418–426. [Google Scholar] [CrossRef] [PubMed]
  43. Liu, A.; Lin, W.; Ping, S.; Guan, W.; Hu, N.; Zheng, S.; Ren, Y. Analysis of degradation and pathways of three common antihistamine drugs by NaClO, UV, and UV-NaClO methods. Environ. Sci. Poll. Res. 2022. [Google Scholar] [CrossRef]
  44. Gadipelly, C.R.; Rathod, V.K.; Marathe, K.V. Persulfate assisted photo-catalytic abatement of cetirizine hydrochloride from aqueous waste: Biodegradability and toxicity analysis. J. Mol. Catal. A Chem. 2016, 414, 116–121. [Google Scholar] [CrossRef]
  45. Volcao, L.M.; Fraga, L.S.; de Lima Brum, R.; de Moura, R.R.; Bernardi, E.; Ramos, D.F.; da Silva, F.M.R., Jr. Toxicity of Biocide Formulations in the Soil to the Gut Community in Balloniscus selowii Brandt, 1983 (Crustacea: Isopoda: Oniscidea). Water Air Soil Pollut. 2020, 231, 306–314. [Google Scholar] [CrossRef]
  46. Keerthisinghe, T.P.; Nguyen, L.N.; Kwon, E.E.; Oh, S. Antiseptic chlorhexidine in activated sludge: Biosorption, antimicrobial susceptibility, and alteration of community structure. J. Environ. Manag. 2019, 237, 629–635. [Google Scholar] [CrossRef]
  47. Sarkar, S.; Bhattacharjee, C. Removal of micro-pollutant using an indigenous photo membrane reactor. J. Environ. Chem. Eng. 2020, 8, 103673. [Google Scholar] [CrossRef]
  48. Schröder, S.; San-Román, M.-F.; Ortiz, I. Dioxins and furans toxicity during the photocatalytic remediation of emerging pollutants. Triclosan as case study. Sci. Total Environ. 2021, 770, 144853. [Google Scholar] [CrossRef]
  49. Pacholak, A.; Burlaga, N.; Frankowski, R.; Zgoła-Grześkowiak, A.; Kaczorek, E. Azole fungicides: (Bio)degradation, transformation products and toxicity elucidation. Sci. Total Environ. 2022, 802, 149917. [Google Scholar] [CrossRef]
  50. Da Silva, W.L.; Lansarin, M.A.; Livotto, P.R.; dos Santos, J.H.Z. Photocatalytic degradation of drugs by supported titania-based catalysts produced from petrochemical plant residue. Powder Technol. 2015, 279, 166–172. [Google Scholar] [CrossRef]
  51. Diaz-Sosa, V.R.; Tapia-Salazar, M.; Wanner, J.; Cardenas-Chavez, D.L. Monitoring and Ecotoxicity Assessment of Emerging Contaminants in Wastewater Discharge in the City of Prague (Czech Republic). Water 2020, 12, 1079. [Google Scholar] [CrossRef]
  52. Mussa, Z.H.; Al-Qaim, F.F.; Yuzir, A.; Hara, H.; Azman, S.; Chelliapan, S. Elucidation and Characterization of New Chlorinated By-Products after Electrochemical Degradation of Hydrochlorothiazide Using Graphite–Poly Vinyl Chloride Electrode. Catalysts 2018, 8, 540. [Google Scholar] [CrossRef] [Green Version]
  53. Hegedus, M.; Lacina, P.; Ploteny, M.; Lev, J.; Kamenicka, B.; Weidlich, T. Fast and efficient hydrodehalogenation of chlorinated benzenes in real wastewaters using Raney alloy. J. Water Proc. Eng. 2020, 38, 101645. [Google Scholar] [CrossRef]
  54. Moser, P.; Sallmann, A.; Wiesenberg, I. Synthesis and quantitative structure-activity relationships of diclofenac analogs. J. Med. Chem. 1990, 33, 2358–2368. [Google Scholar] [CrossRef] [PubMed]
  55. Jalal, A.; Shahzadi, S.; Shahid, K.; Ali, S.; Badshah, A.; Mazhar, M.; Khan, K.M. Preparation, spectroscopic studies and biological activity of mono-organotin (IV) derivatives of non-steroidal anti-inflammatory drugs. Turk. J. Chem. 2004, 28, 629–644. [Google Scholar]
  56. Kourkoumelis, N.; Demertzis, M.A.; Kovala-Demertzi, D.; Koutsodimou, A.; Moukarika, A. Preparations and spectroscopic studies of organotin complexes of diclofenac. Spectrochim. Acta A 2004, 60, 2253–2259. [Google Scholar] [CrossRef]
  57. Shindikar, A.V.; Khan, F.; Viswanathan, C.L. Design, synthesis and in vivo anticonvulsant screening in mice of novel phenylacetamides. Eur. J. Med. Chem. 2006, 41, 786–792. [Google Scholar] [CrossRef]
  58. Japanese National Institute of Advanced Industrial Science and Technology. Available online: https://sdbs.db.aist.go.jp (accessed on 20 December 2021).
  59. Monguchi, Y.; Kume, A.; Hattori, K.; Maegawa, T.; Sajiki, H. Pd/C–Et3N-mediated catalytic hydrodechlorination of aromatic chlorides under mild conditions. Tetrahedron 2006, 62, 7926–7933. [Google Scholar] [CrossRef]
  60. EVA. Diffracplus Basic Evaluating Package, Version 19; Bruker AXS GmbH: Billerica, MA, USA, 2013. [Google Scholar]
  61. ICDD. Joint Committee on Powder Diffraction Standards, International Centre of Diffraction Data; ICDD: Swarthmore, PA, USA, 1995. [Google Scholar]
Figure 1. Comparison of HDC of DBF at 25 °C at conditions used in (a) run No. 1 in Table 2. ([DCF]0 = 2 mM; [Al-Ni]0 = 1.65 g L−1 (30 mM Al); [KOH]0 = 8.5 g L−1 (150 mM KOH). Experimental (symbols) and model fit (solid lines); (b) different quantities of reagents, mentioned quantity of Al added in Al-Ni alloy, [DCF] = 2 mM; (c) with and without the addition of glucose, [DCF]0 = 2 mM; 20 mmol L−1 Al in Al-Ni alloy and 100 mmol L−1 KOH; (d) using different amount of KOH (2 mmol L−1 DCF + 20 mmol L−1 Al in Al-Ni alloy).
Figure 1. Comparison of HDC of DBF at 25 °C at conditions used in (a) run No. 1 in Table 2. ([DCF]0 = 2 mM; [Al-Ni]0 = 1.65 g L−1 (30 mM Al); [KOH]0 = 8.5 g L−1 (150 mM KOH). Experimental (symbols) and model fit (solid lines); (b) different quantities of reagents, mentioned quantity of Al added in Al-Ni alloy, [DCF] = 2 mM; (c) with and without the addition of glucose, [DCF]0 = 2 mM; 20 mmol L−1 Al in Al-Ni alloy and 100 mmol L−1 KOH; (d) using different amount of KOH (2 mmol L−1 DCF + 20 mmol L−1 Al in Al-Ni alloy).
Materials 15 03939 g001
Scheme 1. Scheme of stepwise HDC of DCF salt in alkaline aqueous solution using Raney Al-Ni/KOH mixture.
Scheme 1. Scheme of stepwise HDC of DCF salt in alkaline aqueous solution using Raney Al-Ni/KOH mixture.
Materials 15 03939 sch001
Figure 2. The SEM photos show the morphology of (a) starting commercial Raney Al-Ni alloy; (b) eroded Al-Ni alloy after HDC process (run No. 7 in Table 2); (c) used Al-Ni alloy in co-action of glucose, run No. 8 in Table 2; (d) cubic Ni particles obtained by action of NaOH/NaBH4 (run No.15 in Table 2).
Figure 2. The SEM photos show the morphology of (a) starting commercial Raney Al-Ni alloy; (b) eroded Al-Ni alloy after HDC process (run No. 7 in Table 2); (c) used Al-Ni alloy in co-action of glucose, run No. 8 in Table 2; (d) cubic Ni particles obtained by action of NaOH/NaBH4 (run No.15 in Table 2).
Materials 15 03939 g002
Table 1. The comparison of published methods tested for DCF destruction at 25 °C.
Table 1. The comparison of published methods tested for DCF destruction at 25 °C.
Tested AOP MethodConcentration of DCF in aq. SolutionQuantity of ReagentReaction Conditions:Conversion of DCFRef. No.:
HDH20 mg L−1H2 bubbling:
50 NmL min.−1
Pd/Al2O3 (1 wt.% Pd)
0.5 g L−1
100% after 30 min.[4]
Electro-Fenton7.5 mg L−1 in 10 mM Na2SO4air bubbling
(1 L/min.)
pH = 3, BDDE,
El. current:
300 mA per 150 mL of DCF sol.
90% after 30 min.[13]
Sonolysis7.5 mg L−1Ultrasound
40 kHz
pH = 345% after 30 min.[13]
Sonolysis7.5 mg L−1Ultrasound
120 kHz
pH = 385% after 30 min.[13]
Electron-beam irradiation50 mg L−1radiation
dose 5.0 kGy
Dynamitron
Electron Beam Accelerator at 37.5 kW and 1.4 MeV
100%
(or 30% at 1.0 kGy)
after 15 min.
[15]
Photo-Fenton0.1 mg DCF L−1
+ 5 other tested micropollutants at the same concentration
1.47 mM of H2O2 and Fe3+
+ ethylene-diamine-N,N′ -disuccinic acid complex 1:1
30 min using 30 W m−2 UVA radiation
(λ 300–400 nm),
more than 80% after 30 min of irradiation[16]
Heterogeneous
photo-Fenton
5 and 10 mg L−12.0 g L−1 of boron-doped graphitic carbon nitride (C3N4) dopped with 5 wt.% V2O540 mL of DCF sol. in array of 8 W monochromatic blue lamps each
(λ 465 ± 40 nm),
more than 70% of DCF after 30 min.
(100% removal after 100 min.)
[17]
Heterogeneous
photo-Fenton
40 mg L−11.2 mL L−1 H2O2 (30%)
+ 0.2 g L−1 CoFe2O4
500 mL tubular reactor equipped with an 8 W monochromatic UV germicide radiation
(254 nm)
100% of DCF after 30 min of irradiation[18]
Table 2. HDC efficiencies of DCF using a different quantity and type of reductants.
Table 2. HDC efficiencies of DCF using a different quantity and type of reductants.
Run aQuantity of KOH (mmol)Quantity of Al-Ni Alloy (Quantity of Al) bAdditive (mmol)Conversion to APA
1300.33 g (6 mmol)no100%
230decanted Al-Ni
from exp. No. 9
no53% (39% of DCF;
8% of Cl-APA)
3 c300.33 g (6 mmol)no100%
4250.27 g (5 mmol)no100%
5400.22 g (4 mmol)no100%
6300.22 g (4 mmol)no100%
7200.22 g (4 mmol)no100%
8200.22 g (4 mmol)5 of glucose100%
9200.22 g (4 mmol)10 of glucose83% (11% of DCF;
6% of Cl-APA)
10100.22 g (4 mmol)no100%
11150.17 g (3 mmol)no94% (4% of DCF;
2% of Cl-APA)
12100.11 g (2 mmol)no69% (25% of DCF;
6% of Cl-APA)
13200.11 g (2 mmol)no93% (6% of DCF;
1% Cl-APA)
14200.27 g of Al (10 mmol)no0%
15 d192 of NaOHdecanted Al-Ni
used in run No. 3
31 of NaBH489% (8% of DCF;
3% of Cl-APA)
16 e00200 of NaBH4 + 10 of NiSO436% (40% of DCF;
24% of Cl-APA)
a An amount of 0.4 mmol of NaDCF dissolved in water (200 mL), stirred overnight at 750 rpm, 25 °C. b Added as Al-Ni alloy. c An amount of 0.4 mmol of NaDCF dissolved in tap water (200 mL) was used in this run. An amount of d 10 g of commercial 12 wt.% NaBH4 in 14 M aq. NaOH was used instead of KOH. e Powdered NaBH4 and 10 mL of dropwise added 1 M aqueous NiSO4 was used as a source of Ni and reduction agent instead of KOH and Al-Ni.
Table 3. Rate constants k1, k2 and reaction half times t1/2 for different quantities of reagents using aqueous 2 mmol L−1 DCF at 25 °C.
Table 3. Rate constants k1, k2 and reaction half times t1/2 for different quantities of reagents using aqueous 2 mmol L−1 DCF at 25 °C.
Run aQuantity of KOH (mmol L−1)Quantity of Al-Ni Alloy (g L−1) (mmol L−1 Al)k1 (min−1)k2 (min−1)t1/2 (min)
11501.65 (30)0.130.385
41251.35 (25)0.0620.2311
52001.10 (20)0.0460.1515
61501.10 (20)0.0350.1420
71001.10 (20)0.0320.1422
8 b1001.10 (20)0.0220.1032
10501.10 (20)0.0240.1229
a The numbering corresponds with numbering in Table 2. b 25 mmol L−1 of glucose was added to the reaction mixture.
Table 4. A comparison of removal efficiency of 9 aromatic or heterocyclic halogenated biocides using different reductants determined using HPLC-MS (see the Supplementary Material for more details).
Table 4. A comparison of removal efficiency of 9 aromatic or heterocyclic halogenated biocides using different reductants determined using HPLC-MS (see the Supplementary Material for more details).
Run No.Used HDH Procedure Triclosan
(μg L−1)
DCF
(μg L−1)
Hydrochlorothiazid
(μg L−1)
Cetirizine
(μg L−1)
Chlorhexidine
(μg L−1)
Ketoconazole
(μg L−1)
Atrazine
(μg L−1)
Fluconazol
(μg L−1)
Simazine
(μg L−1)
-Starting aq. solution
of biocides (WW)
11.8614.016.413.21.7313.9614.710.510.7
1WW + NaBH4 a9.9813.715.511.20.968.5614.5810.210.6
2WW + Al-Ni/NaOH b2.082.00.10.60.3700.11.44.0
3WW + NaBH4/NiSO4 c6.062.030.100.60.008.020.14.0
41. WW + NaBH4/NiSO4;
2. +Al-Ni/NaOH d
0.10.3000.2000.10
a Action of 5 mmol L−1 of NaBH4; pH = 9.5; reaction time 30 min at room temperature. b An amount of 0.54 g Al-Ni (contains 10 mmol L−1 Al and 4.6 mmol L−1 Ni) + 50 mmol L−1 Al NaOH. c Action of 5 mmol L−1 of NaBH4 + 2 mmol L−1 of NiSO4. d An amount of 2 mmol L−1 NiSO4 + 5 mmol L−1 NaBH4 (30 min.) and subsequent addition of 0.54 g L−1 of Al-Ni alloy (10 mmol L−1 Al + 4.6 mmol L−1 of Ni) and 50 mmol L−1 NaOH; reaction time 16 h at room temperature.
Table 5. Details dealing with the HDC of DCF in hospital wastewater spiked with DCF.
Table 5. Details dealing with the HDC of DCF in hospital wastewater spiked with DCF.
Sample DescriptionContent of DCF
(and HDC Products)
Content of AOXContent of BODContent of CODCr
Starting hospital wastewater + DCF
(content of DCF 1 mmol L−1)
100%73.52191374
(1) 150 mmol L−1 NiSO4
+ 150 mmol L−1 NaBH4
in 450 mmol L−1 aq. NaOH
Not measured63.911511965
(2) +25 mmol L−1 Al (in Al-Ni)0% (0% Cl-APA;
100% APA)
0.17295608
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bendová, H.; Kamenická, B.; Weidlich, T.; Beneš, L.; Vlček, M.; Lacina, P.; Švec, P. Application of Raney Al-Ni Alloy for Simple Hydrodehalogenation of Diclofenac and Other Halogenated Biocidal Contaminants in Alkaline Aqueous Solution under Ambient Conditions. Materials 2022, 15, 3939. https://doi.org/10.3390/ma15113939

AMA Style

Bendová H, Kamenická B, Weidlich T, Beneš L, Vlček M, Lacina P, Švec P. Application of Raney Al-Ni Alloy for Simple Hydrodehalogenation of Diclofenac and Other Halogenated Biocidal Contaminants in Alkaline Aqueous Solution under Ambient Conditions. Materials. 2022; 15(11):3939. https://doi.org/10.3390/ma15113939

Chicago/Turabian Style

Bendová, Helena, Barbora Kamenická, Tomáš Weidlich, Ludvík Beneš, Milan Vlček, Petr Lacina, and Petr Švec. 2022. "Application of Raney Al-Ni Alloy for Simple Hydrodehalogenation of Diclofenac and Other Halogenated Biocidal Contaminants in Alkaline Aqueous Solution under Ambient Conditions" Materials 15, no. 11: 3939. https://doi.org/10.3390/ma15113939

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop